Silke Baasner

509 total citations
15 papers, 412 citations indexed

About

Silke Baasner is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Silke Baasner has authored 15 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Silke Baasner's work include Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Silke Baasner is often cited by papers focused on Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Silke Baasner collaborates with scholars based in Germany, Netherlands and France. Silke Baasner's co-authors include E Günther, Thomas Beckers, Matthias Gerlach, Péter Schmidt, Konrad J. Böhm, Eberhard Unger, Helge Prinz, Klaus Müller, Siavosh Mahboobi and Herwig Pongratz and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Critical Care.

In The Last Decade

Silke Baasner

15 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Baasner Germany 12 252 126 67 37 34 15 412
Ryoichi Ando Japan 14 167 0.7× 124 1.0× 76 1.1× 27 0.7× 25 0.7× 29 461
Scott A. Long United States 9 189 0.8× 212 1.7× 56 0.8× 42 1.1× 21 0.6× 13 429
Athanasios Papageorgiou Greece 10 135 0.5× 157 1.2× 143 2.1× 21 0.6× 18 0.5× 22 449
Daniela Piras Italy 10 179 0.7× 184 1.5× 35 0.5× 25 0.7× 15 0.4× 21 479
Thomas Maduskuie United States 12 129 0.5× 210 1.7× 93 1.4× 44 1.2× 8 0.2× 22 477
Kyung-Hwa Jeon South Korea 12 226 0.9× 212 1.7× 56 0.8× 51 1.4× 83 2.4× 13 393
Craig I. Turner Australia 14 285 1.1× 258 2.0× 31 0.5× 86 2.3× 7 0.2× 18 599
Diana Ayán Canada 11 64 0.3× 105 0.8× 23 0.3× 17 0.5× 20 0.6× 23 302
Jean-Pierre Evenou Switzerland 6 79 0.3× 190 1.5× 59 0.9× 20 0.5× 12 0.4× 7 323
Robert V. Moquin United States 14 357 1.4× 224 1.8× 98 1.5× 28 0.8× 18 0.5× 19 568

Countries citing papers authored by Silke Baasner

Since Specialization
Citations

This map shows the geographic impact of Silke Baasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Baasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Baasner more than expected).

Fields of papers citing papers by Silke Baasner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Baasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Baasner. The network helps show where Silke Baasner may publish in the future.

Co-authorship network of co-authors of Silke Baasner

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Baasner. A scholar is included among the top collaborators of Silke Baasner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Baasner. Silke Baasner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Todorov, Hristo, Antje Gottschalk, Silke Baasner, et al.. (2017). Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery - a retrospective data analysis. BMC Anesthesiology. 17(1). 163–163. 30 indexed citations
2.
Ergin, Bülent, Lara Zafrani, Aslı Kandil, et al.. (2016). Fully Balanced Fluids do not Improve Microvascular Oxygenation, Acidosis and Renal Function in a Rat Model of Endotoxemia. Shock. 46(1). 83–91. 17 indexed citations
3.
Baasner, Silke, et al.. (2013). Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?. Critical Care. 17(3). 311–311. 20 indexed citations
4.
Prinz, Helge, Péter Schmidt, Konrad J. Böhm, et al.. (2011). Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents—synthesis, antiproliferative activity and inhibition of tubulin polymerization. Bioorganic & Medicinal Chemistry. 19(14). 4183–4191. 17 indexed citations
5.
Schmidt, Péter, Konrad J. Böhm, Silke Baasner, et al.. (2010). Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety. European Journal of Medicinal Chemistry. 45(8). 3420–3438. 22 indexed citations
6.
Marchand, Pascal, et al.. (2009). Synthesis and structure–activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents. Bioorganic & Medicinal Chemistry. 17(18). 6715–6727. 20 indexed citations
7.
Prinz, Helge, Péter Schmidt, Konrad J. Böhm, et al.. (2009). 10-(2-oxo-2-Phenylethylidene)-10H-anthracen-9-ones as Highly Active Antimicrotubule Agents: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization. Journal of Medicinal Chemistry. 52(5). 1284–1294. 26 indexed citations
8.
Marchand, Pascal, et al.. (2008). Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 23(5). 686–695. 2 indexed citations
9.
Zuse, Anne, Péter Schmidt, Silke Baasner, et al.. (2007). Sulfonate Derivatives of Naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-Anthracenone as Highly Active Antimicrotubule Agents. Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization. Journal of Medicinal Chemistry. 50(24). 6059–6066. 45 indexed citations
10.
Zuse, Anne, Péter Schmidt, Silke Baasner, et al.. (2006). 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as Novel Antimicrotubule AgentsSynthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization. Journal of Medicinal Chemistry. 49(26). 7816–7825. 22 indexed citations
11.
Baasner, Silke, et al.. (2004). 4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization. Cancer Research. 64. 1252–1252. 1 indexed citations
12.
Gerlach, Matthias, et al.. (2004). Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides. Archiv der Pharmazie. 337(12). 695–703. 5 indexed citations
13.
Mahboobi, Siavosh, Steffen Teller, Herwig Pongratz, et al.. (2002). Bis(1H-2-indolyl)methanones as a Novel Class of Inhibitors of the Platelet-Derived Growth Factor Receptor Kinase. Journal of Medicinal Chemistry. 45(5). 1002–1018. 68 indexed citations
14.
Mahboobi, Siavosh, Herwig Pongratz, Jörg Hockemeyer, et al.. (2001). Synthetic 2-Aroylindole Derivatives as a New Class of Potent Tubulin-Inhibitory, Antimitotic Agents. Journal of Medicinal Chemistry. 44(26). 4535–4553. 91 indexed citations
15.
Baasner, Silke, Harald von Melchner, T. Klenner, P. Hilgard, & Thomas Beckers. (1996). Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.. PubMed. 13(5). 901–11. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026